Sphere Fluidics: Single cell analysis has never looked so disruptive

By Shane Schutte

Sphere Fluidics is an Everline Future 50 company pioneering the development of new technology for single cell analysis. Cyto-Mine is the first machine of its kind and enables analysis of millions of single cells in novel biochips and isolation of rare variants which cause disease. This will also allow them to produce new medicines.